Comparative safety of bedaquiline and delamanid in patients with multidrug resistant tuberculosis: A nationwide retrospective cohort study
Background/Purpose(s): Bedaquiline and delamanid were recently approved for multidrug resistant tuberculosis (MDR-TB). Bedaquiline carries a black box warning of increased risk of death compared to the placebo arm, and there is a need to establish the risks of QT prolongation and hepatotoxicity for...
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado em: |
Elsevier
2023-08-01
|
| Colecção: | Journal of Microbiology, Immunology and Infection |
| Assuntos: | |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S1684118223000877 |